Recombinant DNA (rDNA) refers to artificial DNA molecules that are created by combining genetic material from different sources. This technology involves the insertion of DNA fragments from one ...

Genetic engineering, also known as genetic modification, is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to ...

In 1976, the prospect of genetic engineering research in local laboratories set off a historic debate among scientists and concerned citizens.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced a major milestone for Project Atlas, the Company ...

Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

Last week, in part one of this two part series on commercial genetic engineering laboratories. Synapse looked inside two of ...

Fifty years ago today, scientists met to set safety limits on the new field of genetic engineering. This week researchers meet again to discuss big questions as biotechnology grows more powerful.

Recombinant Bacillus Calmette-Guérin (rBCG) technologies harness the century-old live attenuated Mycobacterium bovis BCG backbone and augment it through genetic engineering to express heterologous ...

In the mid-1980s, an article in a popular science magazine that talked about genetic engineering—recombinant DNA technologies, cloning, and related advances—caught my attention as a high schooler in ...

Matthew Cobb is professor emeritus at the University of Manchester, UK, and author of The Genetic Age (Profile Books, 2022). On 24 February 1975, some 150 people met at the Asilomar Conference Grounds ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

Boost ROI through animal-free, high-purity supplements, next-gen protein innovation, strategic partnerships, capacity expansion and emerging biotech hubsDublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- ...